Literature DB >> 27176920

Protocadherin-10 acts as a tumor suppressor gene, and is frequently downregulated by promoter methylation in pancreatic cancer cells.

Chan Qiu1, Xiaona Bu1, Zheng Jiang1.   

Abstract

Protocadherin-10 (PCDH10), a member of non-clustered protocadherin family which plays important roles in calcium-dependent cell-cell signal transduction and adhesion. PCDH10 functions as a tumor suppressor gene and its expression is downregulated by promoter methylation in many malignances. In the present study, we explored PCDH10 expression and promoter methylation status, and its biological effects in pancreatic cancer cells, and furthermore, we explored the mechanism of PCDH10 preliminary in pancreatic cancer cells. the mRNA level of PCDH10 was detected by semi-quantitative reverse transcription PCR and promoter methylation status examined by methylation-specific PCR in the pancreatic cancer cells (Capan-1, Panc-1, AsPC-1 and BxPC-3) as well as the human normal pancreatic ductal epithelial cells HPDE6-C7 which was used as a control. The human pancreatic cells were transfected with plasmid pcDNA3.1-PCDH10 or pcDNA3.1 by lipofectamine 2000. The biological function of PCDH10 in pancreatic cancer cells was determined by CCK-8 assay, colony formation assay, flow cytometry, Transwell invasion assay and wound-healing assay. The levels of apoptosis related proteins were examined by western blotting. PCDH10 expression was obviously downregulated in the pancreatic cancer cells (Capan-1, Panc-1, BxPC-3) compared to the normal pancreatic ductal epithelial cells. PCDH10 promoter methylation was observed in the two pancreatic cancer cells Capan-1 and BxPC-3,and the expression of PCDH10 could be restored after treating with 5-aza-2'-deoxycytidine and trichostatin A in the two cell types. Overexpression of PCDH10 can inhibit the proliferation, migration, invasion ability of pancreatic cancer cells and induce apoptosis. Ectopic expression of PCDH10 could increase the levels of PARP, caspase-3, caspase-9 and decrease the level of bcl-2, AKT and p-AKT. PCDH10 acts as a tumor suppressor gene, and is frequently down-regulated by promoter methylation in pancreatic cancer cells. PCDH10 may induce cancer cell apoptosis via the AKT pathway.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27176920     DOI: 10.3892/or.2016.4793

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  9 in total

1.  PCDH10 gene inhibits cell proliferation and induces cell apoptosis by inhibiting the PI3K/Akt signaling pathway in hepatocellular carcinoma cells.

Authors:  Mingxin Ye; Jinzheng Li; Jianping Gong
Journal:  Oncol Rep       Date:  2017-05-05       Impact factor: 3.906

2.  Dipeptidyl peptidase like 6 promoter methylation is a potential prognostic biomarker for pancreatic ductal adenocarcinoma.

Authors:  Xin Zhao; Di Cao; Zhangyong Ren; Zhe Liu; Shaocheng Lv; Jiqiao Zhu; Lixin Li; Ren Lang; Qiang He
Journal:  Biosci Rep       Date:  2020-07-31       Impact factor: 3.840

3.  Aberrant promoter methylation of PCDH10 as a potential diagnostic and prognostic biomarker for patients with breast cancer.

Authors:  Wentao Liu; Jin Wu; Guangyue Shi; Xiaolong Yue; Dan Liu; Qingyuan Zhang
Journal:  Oncol Lett       Date:  2018-07-25       Impact factor: 2.967

4.  Innovative mouse models for the tumor suppressor activity of Protocadherin-10 isoforms.

Authors:  Irene Kleinberger; Ellen Sanders; Katrien Staes; Marleen Van Troys; Shinji Hirano; Tino Hochepied; Kelly Lemeire; Liesbet Martens; Christophe Ampe; Frans van Roy
Journal:  BMC Cancer       Date:  2022-04-25       Impact factor: 4.638

5.  Synergistic Antitumoral Effect of Epigenetic Inhibitors and Gemcitabine in Pancreatic Cancer Cells.

Authors:  Immacolata Maietta; Amparo Martínez-Pérez; Rosana Álvarez; Ángel R De Lera; África González-Fernández; Rosana Simón-Vázquez
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-02

6.  PCDH20 inhibits esophageal squamous cell carcinoma proliferation and migration by suppression of the mitogen-activated protein kinase 9/AKT/β-catenin pathway.

Authors:  Yijiao Ning; Chaoqun Deng; Chunhong Li; Weiyan Peng; Chun Yan; Jing Ran; Weihong Chen; Yujia Liu; Jiuyi Xia; Lin Ye; Zhengqiang Wei; Tingxiu Xiang
Journal:  Front Oncol       Date:  2022-09-28       Impact factor: 5.738

7.  Decreased expression of protocadherin 20 is associated with poor prognosis in hepatocellular carcinoma.

Authors:  Yanqin Wu; Shuhui Zheng; Jiayan Yao; Minrui Li; Guang Yang; Ning Zhang; Shenghong Zhang; Bihui Zhong
Journal:  Oncotarget       Date:  2017-01-10

8.  Identification of Key Candidate Genes and Pathways in Endometrial Cancer by Integrated Bioinformatical Analysis

Authors:  Lihong Liu; Fangxu Chen; Aihui Xiu; Bo Du; Hao Ai; Wei Xie
Journal:  Asian Pac J Cancer Prev       Date:  2018-04-25

9.  Acceleration in the DNA methylation age in breast cancer tumours from very young women.

Authors:  Sara S Oltra; Maria Peña-Chilet; Kirsty Flower; María Teresa Martinez; Elisa Alonso; Octavio Burgues; Ana Lluch; James M Flanagan; Gloria Ribas
Journal:  Sci Rep       Date:  2019-10-18       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.